MEDINCELL.

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Oct 2024 filing date already counts against anyone who files later.

Record

Serial number

79413864

Mark type

Word mark

Filed

17 Oct 2024

Attorney of record

Jonathan M. Gelchinsky

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in contraception, for the treatment of schizophrenia, bipolar disorder, bipolar depression, and major depressive disorders, and for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; veterinary preparations and substances for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, diseases and disorders, and for the treatment of substance abuse related diseases and disorders; pharmaceutical compositions for use in contraception, for the treatment of schizophrenia, bipolar disorder, bipolar depression, and major depressive disorders, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, diseases and disorders, and for the treatment of substance abuse related diseases and disorders; chemical preparations for medical or pharmaceutical use for use in contraception, for the treatment of schizophrenia, bipolar disorder, bipolar depression, and major depressive disorders, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; carriers for pharmaceutical and veterinary preparations being drug delivery agents in the form of dissolvable films, and coatings for tablets that facilitate the delivery of pharmaceutical and veterinary pharmaceutical preparations for use in contraception, for the treatment of schizophrenia, bipolar disorder, bipolar depression, and major depressive disorders, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; bacteriological culture or cell culture mediums for pharmaceutical and veterinary preparations being drug delivery agents comprised of compounds for facilitating the delivery of pharmaceutical and veterinary pharmaceutical preparations for use in contraception, for the treatment of schizophrenia, bipolar disorder, bipolar depression, and major depressive disorders, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; pharmaceutical and veterinary preparations and substances for subcutaneous delivery for use in contraception, for the treatment of schizophrenia, bipolar disorder, bipolar depression, and major depressive disorders, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders
• Class 009 — Scientific and electric apparatus: Scientific apparatus and instruments, namely, tools for injecting and administering liquid formulations into testing equipment or other drug delivery devices; laboratory apparatus and instruments for extracting excipients or active pharmaceutical ingredients from in situ forming depots, not for medical purposes; apparatus and instruments for chemical analysis, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis; apparatus and instruments for measuring, testing and analysing chemical compositions; apparatus for analysing gases; weighing apparatus and instruments; measuring apparatus and instruments, namely, flow controllers; recorded or downloadable computer software for the quantitative long-term monitoring of the release pharmaceutical ingredients into a patient's body; computer hardware
• Class 042 — Scientific and technological services: Laboratory research, testing and research laboratory analysis services in the field of drug delivery; laboratory services, namely, medical research laboratories; chemical analysis; medical, scientific and industrial research in the field of long-acting injectable compositions and providing information relating thereto; pharmaceutical drug development services; pharmaceutical research and development services; rental of laboratory apparatus and instruments; design and development of laboratory and diagnostic apparatus; development and testing of algorithms and software; consultancy in the field of pharmaceutical research and development; services for assessing the efficiency of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals, chemical analysis and clinical trials; providing scientific research information; scientific research in the fields of medicine, pharmacology and veterinary medicine

Owner

• MedinCell S.A., FR

Prosecution history

• 28 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 27 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 27 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 27 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 15 Nov 2025 — REFUSAL PROCESSED BY IB
• 29 Oct 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
• 29 Oct 2025 — REFUSAL PROCESSED BY MPU
• 02 Oct 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
• 02 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 02 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 02 Oct 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 02 Oct 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 11 Sept 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
• 10 Sept 2025 — NON-FINAL ACTION WRITTEN
• 06 Sept 2025 — ASSIGNED TO EXAMINER